Provider

The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.

The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.

Renato Umeton, director of AI operations and data science at Dana-Farber Cancer Institute, discusses building a secure environment to test and deploy LLMs to ensure responsible use, continuous innovation and limited access to outside AI tools.  

The algorithms are used to detect valvular heart disease.

The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.

Steen Strand, CEO of Emteq Labs, discusses the company's launch of Sense, emotion-sensing eyewear that collects real-world data on a wearer's facial expressions and its potential use for healthcare data collection.

The AHA and MDisrupt will also co-develop a platform to enable expert referrals and disseminate evidence-based science to healthcare technology innovators. 

The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.

Dr. Zafar Chaudry, Seattle Children's chief digital officer and chief AI and information officer, discusses the importance of effective change management during AI implementation - and using AI as a tool rather than a stand-alone solution.  

The AI-enabled technology measures musculoskeletal structures from an MRI scan.